tiprankstipranks
Advertisement
Advertisement
Natera initiated with a Neutral at Goldman Sachs
PremiumThe FlyNatera initiated with a Neutral at Goldman Sachs
16d ago
Natera, CytoDyn collaborate to advance ctDNA-guided development
Premium
The Fly
Natera, CytoDyn collaborate to advance ctDNA-guided development
17d ago
Natera appoints Lynch, Rubin to board of directors
Premium
The Fly
Natera appoints Lynch, Rubin to board of directors
18d ago
Natera announces expansion into Austin, creating largest sequencing factory
PremiumThe FlyNatera announces expansion into Austin, creating largest sequencing factory
1M ago
Natera announces Expand trial enrolled over 2,000 patients
Premium
The Fly
Natera announces Expand trial enrolled over 2,000 patients
1M ago
FDA approves Genentech’s Tecentriq for adjuvant muscle-invasive bladder cancer
Premium
The Fly
FDA approves Genentech’s Tecentriq for adjuvant muscle-invasive bladder cancer
1M ago
Natera price target raised to $270 from $250 at Evercore ISI
PremiumThe FlyNatera price target raised to $270 from $250 at Evercore ISI
1M ago
Natera price target raised to $265 from $257 at Baird
Premium
The Fly
Natera price target raised to $265 from $257 at Baird
1M ago
Natera price target raised to $265 from $260 at JPMorgan
Premium
The Fly
Natera price target raised to $265 from $260 at JPMorgan
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100